The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4400 | 2018 |
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial JS Weber, SP D'Angelo, D Minor, FS Hodi, R Gutzmer, B Neyns, ... The lancet oncology 16 (4), 375-384, 2015 | 2965 | 2015 |
The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2598 | 2015 |
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA MC Liu, GR Oxnard, EA Klein, C Swanton, MV Seiden, MC Liu, ... Annals of Oncology 31 (6), 745-759, 2020 | 969 | 2020 |
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration W Abida, A Patnaik, D Campbell, J Shapiro, AH Bryce, R McDermott, ... Journal of Clinical Oncology 38 (32), 3763-3772, 2020 | 558 | 2020 |
Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types M Seiler, S Peng, AA Agrawal, J Palacino, T Teng, P Zhu, PG Smith, ... Cell reports 23 (1), 282-296. e4, 2018 | 379 | 2018 |
Integrated molecular characterization of testicular germ cell tumors H Shen, J Shih, DP Hollern, L Wang, R Bowlby, SK Tickoo, V Thorsson, ... Cell reports 23 (11), 3392-3406, 2018 | 365 | 2018 |
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma MJ Borad, MD Champion, JB Egan, WS Liang, R Fonseca, AH Bryce, ... PLoS genetics 10 (2), e1004135, 2014 | 357 | 2014 |
Non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON2 … W Abida, D Campbell, A Patnaik, JD Shapiro, B Sautois, NJ Vogelzang, ... Clinical Cancer Research 26 (11), 2487-2496, 2020 | 341 | 2020 |
Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome NJ Samadder, D Riegert-Johnson, L Boardman, D Rhodes, M Wick, ... JAMA oncology 7 (2), 230-237, 2021 | 202 | 2021 |
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD … ES Antonarakis, P Isaacsson Velho, W Fu, H Wang, N Agarwal, ... JCO precision oncology 4, 370-381, 2020 | 172 | 2020 |
PD-1 and PD-L1 expression in renal cell carcinoma with sarcomatoid differentiation RW Joseph, SZ Millis, EM Carballido, D Bryant, Z Gatalica, S Reddy, ... Cancer immunology research 3 (12), 1303-1307, 2015 | 163 | 2015 |
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome A Dispenzieri, MQ Lacy, SR Hayman, SK Kumar, F Buadi, D Dingli, ... European journal of haematology 80 (5), 397-406, 2008 | 150 | 2008 |
NCCN guidelines® insights: prostate cancer, version 1.2023: featured updates to the NCCN guidelines EM Schaeffer, S Srinivas, N Adra, Y An, D Barocas, R Bitting, A Bryce, ... Journal of the National Comprehensive Cancer Network 20 (12), 1288-1298, 2022 | 149 | 2022 |
Rucaparib or physician’s choice in metastatic prostate cancer K Fizazi, JM Piulats, MN Reaume, P Ostler, R McDermott, JR Gingerich, ... New England Journal of Medicine 388 (8), 719-732, 2023 | 146 | 2023 |
Differential response to olaparib treatment among men with metastatic castration-resistant prostate cancer harboring BRCA1 or BRCA2 versus ATM mutations CH Marshall, AO Sokolova, AL McNatty, HH Cheng, MA Eisenberger, ... European urology 76 (4), 452-458, 2019 | 142 | 2019 |
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience TT DeLeon, MA Salomao, BA Aqel, MB Sonbol, RT Yokoda, AH Ali, ... Journal of gastrointestinal oncology 9 (6), 1054, 2018 | 142 | 2018 |
Evaluation of pre-analytical factors affecting plasma DNA analysis H Markus, T Contente-Cuomo, M Farooq, WS Liang, MJ Borad, ... Scientific reports 8 (1), 7375, 2018 | 127 | 2018 |
Targeting TMPRSS2 in SARS-CoV-2 infection LB Baughn, N Sharma, E Elhaik, A Sekulic, AH Bryce, R Fonseca Mayo Clinic Proceedings 95 (9), 1989-1999, 2020 | 123 | 2020 |
Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer KN Chi, D Rathkopf, MR Smith, E Efstathiou, G Attard, D Olmos, JY Lee, ... Journal of Clinical Oncology 41 (18), 3339-3351, 2023 | 112 | 2023 |